New Options in Helicobacter pylori Eradication: Efficacy, Resistance and Synergy

References

• Dixon JS. Helicobacter pylori eradication—unravelling the facts. Scand J Gastroenterol 1995;30 Suppl 212:48–62.
   Google Scholar
• Harris AW, Misiewicz JJ. Eradication of Helicobacter pylori. Baillières Clin Gastroenterol 1995;9:583–613.
   PubMedGoogle Scholar
• Penston JG, McColl KEL. Eradication of Helicobacter pylori: an objective assessment of current therapies. Br J Clin Pharmacol 1997;43:223–43.
   PubMed Web of Science ®Google Scholar
• Unge P, Berstad A. Pooled analysis of anti-Helicobacter pylori treatment regimens. Scand J Gastroenterol 1996;31 Suppl 220:27–40.
   Google Scholar
• van der Hulst RWM, Keller JJ, Rauws EAJ, Tytgat GNJ. Treatment of Helicobacter pylori infection: a review of the world literature. Helicobacter 1996;1:6–19.
   PubMedGoogle Scholar
• Walsh JH, Peterson WL. The treatment of Helicobacter pylori infection in the management of peptic ulcer disease. New Engl J Med 1995;333:984–91.
   PubMed Web of Science ®Google Scholar
• McColm AA, McLaren A, Klinkert G, Francis MR, Connolly PC, Grinham CJ, et al. Ranitidine bismuth citrate: a novel antiulcer agent with different physico-chemical characteristics and improved biological activity to a bismuth citrate-ranitidine admixture. Aliment Pharmacol Ther 1996;10:241–50.
   PubMed Web of Science ®Google Scholar
• Stables R, Campbell CJ, Clayton NM, Clitherow JW, Grinham CJ, McColm AA, et al. Gastric anti-secretory, mucosal protective, anti-pepsin and anti-Helicobacter properties of ranitidine bismuth citrate. Aliment Pharmacol Ther 1993;7:237–46.
   PubMed Web of Science ®Google Scholar
• Noach LA, Bertola MA, Schwartz MP, Rauws EAJ, Tytgat GNJ. Treatment of H. pylori infection: an evaluation of various therapeutic trials. Eur J Gastro Hepatol 1994;6:585–91.
   Google Scholar
• Peterson WL, Graham DY, Marshall B, Blaser MJ, Genta RM, Klein PD, et al. Clarithromycin as monotherapy for eradication of Helicobacter pylori: a randomized double-blind trial. Am J Gastroenterol 1993;88:1860–4.
   PubMed Web of Science ®Google Scholar
• Adamek RJ, Wegener M, Labenz J, Freitag M, Opferkuch W, Ruhl GH. Medium-term results of oral and intravenous omeprazole/amoxicillin Helicobacter pylori eradication therapy. Am J Gastroenterol 1994;89:39–42.
   PubMed Web of Science ®Google Scholar
• Unge P, Gad A, Eriksson K, Bergman B, Carling L, Ekström P, et al. Amoxicillin added to omeprazole prevents relapse in the treatment of duodenal ulcer patients. Eur J Gastro Hepatol 1993;5:325–31.
   Google Scholar
• Weissfeld A, Simmons D, Rose P, Kidd S, Lukasik N, Siepman N. Susceptibility of Helicobacter pylori to clarithromycin and amoxycillin in the U.S. Gastroenterology 1997;112:A329.
   Google Scholar
• Catalano F, Catanzaro R, Liberti A, Branciforte G, Brogna A. Comparative efficacy of omeprazole in association with amoxicillin or clarithromycin in Helicobacter pylori positive functional dyspepsia. Gut 1995;37 Suppl 2:A15.
   Google Scholar
• Deltenre M, De Koster E, Van Gossum M, De Reuck M, Jonas C. Omeprazole based therapies for eradication of Helicobacter pylori. Gut 1995;37 Suppl 2:A59.
   Google Scholar
• Breuer T, Sudhop T, Malaty HM, Goodman K, Graham DY, Malfertheiner P. Do physicians from different countries treat H. pylori positive ulcer disease differently; a comparison between America and Germany. Gut 1996;39 Suppl 3:A189.
   Google Scholar
• Cayla R, Zerbib F, Talbi P, Megraud F, Lamouliatte H. Pre- and post-treatment clarithromycin resistance of Helicobacter pylori strains: a key factor of treatment failure. Gut 1995;37 Suppl 2:A152.
   Google Scholar
• Olson C, Edmonds A. Primary susceptibility of H. pylori to clarithromycin compared to metronidazole in patients with duodenal ulcers associate with H. pylori infection. Gut 1995;37 Suppl 2:A80.
   Google Scholar
• Osato MS, Reddy R, Graham DY. Metronidazole and clarithromycin resistance among H. pylori isolates from a large hospital in the United States. Gastroenterology 1997;112:A1057.
   Google Scholar
• Craft CJ, Olson C, Siepman N, Edmonds A. Clarithromycin resistance in U.S. and European patients treated with clarithromycin and omeprazole for duodenal ulcer disease associated with H. pylori infection. Gut 1995;37 Suppl 2:A80.
   Google Scholar
• Axon ATR, Ireland A, Lancaster-Smith MJ, Roopram PD. Ranitidine bismuth citrate and clarithromycin twice daily in the eradication of Helicobacter pylori. Aliment Pharmacol Ther 1997;1:81–7.
   Google Scholar
• Paré P, Romaozinho J, Bardhan KD, French PC, Roberts PM. Ranitidine bismuth citrate (RBC) is more effective than omeprazole in the eradication of H. pylori when co-prescribed with clarithromycin. Gastroenterology 1997;112:A251.
   Google Scholar
• Perschy TB, McSorley DJ, Sorrells SC, Webb DD. Ranitidine bismuth citrate in combination with clarithromycin is effective against H. pylori strains with susceptible or intermediate clarithromycin sensitivity. Gastroenterology 1997;112:A257.
   Google Scholar
• Mégraud F, Pichavant R, Palegry D, French PC, Roberts PM, Williamson R. Ranitidine bismuth citrate (RBC) co-prescribed with clarithromycin is more effective in the eradication of Helicobacter pylori than omeprazole with clarithromycin. Gut 1997;41 Suppl 1:A92.
   Google Scholar
• Hentschel E, Brandstatter G, Dragosics B, Hirschl AM, Nemec H, Schutze K, et al. Effect of ranitidine and amoxicillin plus metronidazole on the eradication of Helicobacter pylori and the recurrence of duodenal ulcer. New Engl J Med 1993;328:308–12.
   PubMed Web of Science ®Google Scholar
• Peitz U, Nusch A, Tillenburg B, Starke T, Stolte M, Borsch G, et al. Impact of treatment duration and metronidazole resistance on H. pylori cure with omeprazole, metronidazole, and clarithromycin. Gastroenterology 1997;112:A255.
   PubMedGoogle Scholar
• Lind T, Veldhuyzen van Zanten S, Unge P, Spiller R, Bayerdorffer E, O’Morain C, et al. Eradication of Helicobacter pylori using one-week triple therapies combining omeprazole with two antimicrobials: the MACH 1 study. Helicobacter 1996;1: 138–44.
   Google Scholar
• Krogstad DJ, Moellering Jr RC. Antimicrobial combinations. In: Lorian V, editor. Antibiotics in laboratory medicine. 1st ed. Baltimore: Williams and Wilkins, 1980;537–95.
   Google Scholar
• Mégraud F, Lehn N, Lind T, Bayerdorffer E, O’Morain C, Spiller RC, et al. The MACH 2 study. Helicobacter pylori resistance to antimicrobial agents and its influence on clinical outcome. Gastroenterology 1997;112:A216.
   Google Scholar
• Mégraud F, Trimoulet P, Lamouliatte H, Boyanova L. Bactericidal effect of amoxicillin on Helicobacter pylori in an in vitro model using epithelial cells. Antimicrob Agents Chemother 1991;35:869–72.
   Google Scholar
• McLaren A, McDowell SR, Bagshaw JA, McColm AA. GR122311X in combination with standard agents. Am J Gastroenterol 1994;89:1382.
   Google Scholar
• McLaren A, McDowell SR, Bagshaw JA, McColm AA. The synergistic interaction between GR122311X and clarithromycin against Helicobacter. Am J Gastroenterol 1994;89:1382.
   Google Scholar
• Lopez-Brea M, Domingo D, Sanchez I, Alarcon T. Synergism study of ranitidine bismuth citrate and metronidazole against metronidazole-resistant H. pylori clinical isolates. Gastroenterology 1997;112:A201.
   Google Scholar
• Osato MS, Graham DY. Ranitidine bismuth citrate enhances clarithromycin activity against clinical isolates of H. pylori. Gastroenterology 1997;112:A1057.
   PubMedGoogle Scholar
• Midolo PD, Lambert JR, Kerr TG. Ranitidine bismuth citrate can overcome in vitro antibiotic resistance in Helicobacter pylori. Gut 1997;41 Suppl 1:A12.
   Google Scholar
• Osato MS, Graham DY. Overcoming clarithromycin resistance with the combination of clarithromycin and ranitidine bismuth citrate. Gut 1997;41 Suppl 1:A104.
   Google Scholar
• Cederbrant G, Kahlmeter G, Schalen C, Kamme C. Additive effect of clarithromycin combined with 14-hydroxy clarithromycin, erythromycin, amoxycillin, metronidazole or omeprazole against Helicobacter pylori. J Antimicrob Chemother 1994;34: 1025–9.
   PubMed Web of Science ®Google Scholar
• Midolo PD, Turnidge JD, Lambert JR. Bactericidal activity and synergy studies of proton pump inhibitors and antibiotics against Helicobacter pylori in vitro. J Antimicrob Chemother 1997;39:331–7.
   Google Scholar
• Sjöstrom JE, Fryklund J, Kuhler T, Larsson H. In vitro antibacterial activity of omeprazole and its selectivity for Helicobacter spp. are dependent on incubation conditions. Antimicrob Agents Chemother 1996;40:621–6.
   Google Scholar
• Logan RP, Walker MM, Misiewicz JJ, Gummett PA, Karim QN, Baron JH. Changes in the intragastric distribution of Helicobacter pylori during treatment with omeprazole. Gut 1995;36:12–6.
   PubMed Web of Science ®Google Scholar
• Bardhan KD, Dekkers CP, Lam SK, Nowak A, Schaffalitzky de Muckadell OB, Schutze K, et al. GR122311X (ranitidine bismuth citrate), a new drug for the treatment of duodenal ulcer. Aliment Pharmacol Ther 1995;9: 497–506.
   Google Scholar
• Webb DD, Ciociola AA, Perschy TB, Goodwin BB. Effect of administration of ranitidine bismuth citrate with food on the suppression and eradication of Helicobacter pylori in infected volunteers. Am J Gastroenterol 1995;90:1273–7.
   PubMed Web of Science ®Google Scholar
• Fraser AG, Lam WM, Luk YW, Sercombe J, Sawyerr AM, Hudson M, et al. Effect of ranitidine bismuth citrate on postprandial plasma gastrin and pepsinogens. Gut 1993;34:338–42.
   PubMed Web of Science ®Google Scholar
• Lanza F, Ciociola AA, Sykes DL, Heath A, McSorley DJ, Webb DD. Ranitidine bismuth citrate plus clarithromycin is effective in eradication of H. pylori, healing duodenal ulcers and preventing ulcer relapse. Gastroenterology 1996;110:A172.
   Google Scholar
• Peterson WL, Ciociola AA, Sykes DL, McSorley DJ, Webb DD. Ranitidine bismuth citrate plus clarithromycin is effective for healing duodenal ulcers, eradicating H. pylori and reducing ulcer recurrence. RBC H. pylori Study Group. Aliment Pharmacol Ther 1996;10:251–61.
   Google Scholar
• Lee J, O’Morain C. Consensus or confusion: a review of existing national guidelines on Helicobacter pylori-related disease. Eur J Gastroenterol Hepatol 1997;9:527–31.
   PubMedGoogle Scholar
• Goddard AF, Jessa MJ, Barrett DA, Shaw PN, Idstrom JP, Cederberg C, et al. Effect of omeprazole on the distribution of metronidazole, amoxicillin, and clarithromycin in human gastric juice. Gastroenterology 1996;111:358–67.
   PubMed Web of Science ®Google Scholar
• Gustavson LE, Kaiser JF, Edmonds AL, Locke CS, DeBartolo ML, Schneck DW. Effect of omeprazole on concentrations of clarithromycin in plasma and gastric tissue at steady state. Antimicrob Agents Chemother 1995;39:2078–83.
   PubMed Web of Science ®Google Scholar
• Malfertheiner P, Megraud F, O’Morain C, Bell D, Porro GB, Deltenre M, et al. Current European concepts in the management of Helicobacter pylori infection—the Maastricht consensus report. Eur J Gastroenterol Hepatol 1997;9:1–2.
   PubMed Web of Science ®Google Scholar
• Spinzi G, Bortoli A, Colombo E, Lesinigo E, Venturelli R, Terruzzi V, et al. Randomized study comparing omeprazole plus amoxycillin versus omeprazole plus clarithromycin for eradication of Helicobacter pylori. Aliment Pharmacol Ther 1997;11:317–22.
   PubMedGoogle Scholar
• Unge P, Eriksson K, Bergman B, Carling L, Ekström P, Gad A, et al. Omeprazole and amoxycillin in patients with duodenal ulcer: Helicobacter pylori eradication and remission of ulcers and symptoms during a 6-month follow-up. A double-blind comparative study. Gastroenterology 1992;102:A183.
   Google Scholar
• Eriksson SA. Are ulcer healing and prophylaxis studies appropriately analysed? Eur J Gastro Hepatol 1995;7:1195–8.
   PubMedGoogle Scholar
• Delchier JC, Elamine I, Goldfain D, Chaussade S, Barthelemy P, Idstrom JP. Omeprazole-amoxycillin versus omeprazole-amoxycillin-clarithromycin in the eradication of Helicobacter pylori. Aliment Pharmacol Ther 1996;10:263–8.
   PubMed Web of Science ®Google Scholar